A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This research study is studying a new compound, AZD8205, as a possible treatment for advanced or metastatic solid tumours alone or in combination with anti-cancer agents
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Osoby w wieku 18 lat lub starsze.
- •Pacjenci z nawrotowym lub rozsianym rakiem, którzy byli już leczeni standardowymi metodami.
- •U pacjentów musi być możliwe zmierzenie zmian nowotworowych.
- •Stan ogólny pacjenta musi być dobry (nie powinien być zbyt osłabiony).
- •Przewidywana długość życia pacjenta to co najmniej 12 tygodni.
- •Wystarczająca wydolność szpiku kostnego, wątroby i nerek.
- •Potwierdzony typ nowotworu (np. rak piersi, jajnika, dróg żółciowych, trzonu macicy, płuca o typie płaskonabłonkowym) i stopień zaawansowania.
- •Minimalna waga ciała 30 kg (dla niektórych części badania).
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 16, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (67)
Research Site
Duarte, United States
Research Site
Irvine, United States
Research Site
Santa Monica, United States
Research Site
Santa Rosa, United States
Research Site
Shreveport, United States
Research Site
Baltimore, United States
Research Site
Boston, United States
Research Site
St Louis, United States
Research Site
Albuquerque, United States
Research Site
Commack, United States
Research Site
New York, United States
Research Site
Charlotte, United States
Research Site
Pittsburgh, United States
Research Site
Houston, United States
Research Site
Clayton, Australia
Research Site
Melbourne, Australia
Research Site
Nedlands, Australia
Research Site
Anderlecht, Belgium
Research Site
Leuven, Belgium
Research Site
Calgary, Canada
Research Site
Vancouver, Canada
Research Site
Ottawa, Canada
Research Site
Toronto, Canada
Research Site
Montreal, Canada
Research Site
Beijing, China
Research Site
Beijing, China
Research Site
Changsha, China
Research Site
Changsha, China
Research Site
Chongqing, China
Research Site
Guangzhou, China
Research Site
Kunming, China
Research Site
Shandong, China
Research Site
Budapest, Hungary
Research Site
Budapest, Hungary
Research Site
Budapest, Hungary
Research Site
Milan, Italy
Research Site
Milan, Italy
Research Site
Modena, Italy
Research Site
Roma, Italy
Research Site
Chūōku, Japan
Research Site
Hidaka-shi, Japan
Research Site
Kashiwa, Japan
Research Site
Kōtoku, Japan
Research Site
Kurume-shi, Japan
Research Site
Sunto-gun, Japan
Research Site
Amsterdam, Netherlands
Research Site
Gdansk, Poland
Research Site
Warsaw, Poland
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Barcelona, Spain
Research Site
L'Hospitalet de Llobregat, Spain
Research Site
Madrid, Spain
Research Site
Málaga, Spain
Research Site
Pamplona, Spain
Research Site
Taichung, Taiwan
Research Site
Tainan, Taiwan
Research Site
Taipei, Taiwan
Research Site
Taipei, Taiwan
Research Site
Taoyuan, Taiwan
Research Site
Bangkok, Thailand
Research Site
Chiang Mai, Thailand
Research Site
Cambridge, United Kingdom
Research Site
Cardiff, United Kingdom
Research Site
London, United Kingdom
Trial contact
AstraZeneca Clinical Study Information Center
AstraZeneca Breast Cancer Study Locator Service
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.